Trials / Terminated
TerminatedNCT04852692
A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
A Retrospective/Prospective, Multicenter, Non-interventional, Historical Control Study Investigating Comparative Effectiveness of IMBRUVICA in Steroid Dependent/Refractory cGVHD Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Janssen Korea, Ltd., Korea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of ibrutinib compared to conventional salvage treatments in participants with steroid dependent/refractory chronic graft versus host disease (cGVHD) by measuring overall cGVHD response (modified National Institutes of Health \[NIH\] response defined complete response \[CR\] and partial response \[PR\]) at Week 24.
Conditions
Timeline
- Start date
- 2021-06-21
- Primary completion
- 2021-08-06
- Completion
- 2021-08-06
- First posted
- 2021-04-21
- Last updated
- 2025-05-23
Locations
8 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04852692. Inclusion in this directory is not an endorsement.